Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine. "Appendix B: Participant Biographies." Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020: Workshop Summary. Washington, DC: The National Academies Press, 2012.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Envisioning a Transformed Clinical Trials Enterprise in the United States
at the China Europe International Business School. In 2010–2011, he was a mentor for the Commonwealth Fund’s Harkness Fellowships in Health Care Policy and Practice. He is a voting member of the Medicare Evidence Development and Coverage Advisory Committee. Dr. Schulman received his M.D. from the New York University School of Medicine and his M.B.A., with a concentration in health care management, from the Wharton School of the University of Pennsylvania. He completed a residency in internal medicine at the Hospital of the University of Pennsylvania and is board certified in internal medicine.
Heather M. Snyder, Ph.D., assists with oversight of the Alzheimer’s Association International Research Grant Program, the world’s largest nonprofit initiative to advance Alzheimer’s research. Since 1982, the Association has committed $292 million to more than 2,000 best-of-field investigators worldwide. In addition to assisting with smooth review of proposals and distribution of awards to successful applicants, Dr. Snyder assumes primary responsibility for metrics and qualitative assessments to enhance the program’s effectiveness and impact, and for communicating program results to a wide range of audiences. After earning an undergraduate degree in biology and religious studies at the University of Virginia, Dr. Snyder moved on to graduate and postgraduate studies in Chicago, completing her Ph.D. at Loyola University Chicago Stritch School of Medicine and a postdoctoral fellowship at Children’s Memorial Research Center of Northwestern University.
Scott J. Steele, Ph.D., M.A., serves as the Director of Research Alliances at the University of Rochester. In this role he fosters strategic research partnerships between the University’s research community and industry, government agencies and laboratories, and other academic institutions. He is actively involved with the University of Rochester Clinical and Translational Science Institute, serving as the Director of the Public– Private– Partnerships Key Function. Additionally, he holds an adjunct appointment in the Department of Community and Preventive Medicine. Prior to joining the University of Rochester, Dr. Steele served in the White House Office of Science and Technology Policy (OSTP), initially as a policy analyst and later designated as the Executive Director of the President’s Council of Advisors on Science and Technology (PCAST). Dr. Steele coordinated PCAST studies addressing issues in personalized medicine, nanotechnology, energy technologies, and approaches to enhance university–private sector research partnerships. Previously, Dr. Steele served as a senior policy specialist and intelligence analyst at the Federal Bureau of Investigation (FBI), within the FBI’s Weapons of Mass Destruction program. Dr. Steele received his B.S. with honors in biology from